News Conference News ESC 2018 MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis Todd Neale August 26, 2018
News Conference News ESC 2018 Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61 Michael O'Riordan August 26, 2018
News Daily News Starting Low and Going Lower: Some Benefit to Very Low LDL Levels Michael O'Riordan August 02, 2018
News Daily News Is Weight-Based Dosing of Aspirin Needed for Effective Primary Prevention? Todd Neale July 20, 2018
News Conference News ACC 2018 Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS Michael O'Riordan March 12, 2018
News Daily News Less Aggressive HbA1c Targets Recommended by American College of Physicians Michael O'Riordan March 06, 2018
News Daily News Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II Michael O'Riordan February 21, 2018
News Daily News No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis Michael O'Riordan February 02, 2018
News Daily News USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women Caitlin E. Cox December 12, 2017
News Daily News Blood in Urine Carries Consequences for Patients on Antithrombotics Yael L. Maxwell October 09, 2017
News Daily News Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies L.A. McKeown September 25, 2017
News Daily News Quitting Chronic, Low-Dose Aspirin May Boost Risk of Cardiovascular Events Todd Neale September 25, 2017
News Daily News Secondary Prevention Lagging Behind in Women With Established Coronary Disease Todd Neale September 22, 2017
News Daily News Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis Caitlin E. Cox September 14, 2017
News Mortality and CVD Decline in Patients With Diabetes, but Biggest Strides Seen for Nonfatal Outcomes Michael O'Riordan April 13, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Conference News ACC 2017 Does Hormone Replacement Therapy Curb Atherosclerosis? New Imaging Study Opens Old Questions Shelley Wood March 09, 2017
News Daily News Testosterone Therapy Raises Risk of VTE Early but Not Beyond 6 Months Michael O'Riordan December 01, 2016
News Daily News ‘Lower Is Better’ Mantra for LDL Cholesterol Questioned by New Analysis, but Experts Urge Caution Todd Neale June 22, 2016